vs
Side-by-side financial comparison of Local Bounti Corporation (LOCL) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
Sight Sciences, Inc. is the larger business by last-quarter revenue ($20.4M vs $12.5M, roughly 1.6× Local Bounti Corporation). Sight Sciences, Inc. runs the higher net margin — -20.4% vs -69.8%, a 49.4% gap on every dollar of revenue. On growth, Local Bounti Corporation posted the faster year-over-year revenue change (23.7% vs 6.9%). Sight Sciences, Inc. produced more free cash flow last quarter ($-2.0M vs $-3.6M). Over the past eight quarters, Local Bounti Corporation's revenue compounded faster (21.9% CAGR vs 2.9%).
Local Bounti Corporation is a U.S.-based sustainable indoor agriculture firm growing fresh, pesticide-free leafy greens, herbs and produce via advanced hydroponic and vertical farming tech. It serves North American retail and food service partners, focusing on low environmental impact and stable year-round supply.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
LOCL vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.5M | $20.4M |
| Net Profit | $-8.7M | $-4.2M |
| Gross Margin | 12.2% | 87.3% |
| Operating Margin | -106.1% | -18.0% |
| Net Margin | -69.8% | -20.4% |
| Revenue YoY | 23.7% | 6.9% |
| Net Profit YoY | 76.0% | 64.9% |
| EPS (diluted) | $1.52 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.5M | $20.4M | ||
| Q3 25 | $12.2M | $19.9M | ||
| Q2 25 | $12.1M | $19.6M | ||
| Q1 25 | $11.6M | $17.5M | ||
| Q4 24 | $10.1M | $19.1M | ||
| Q3 24 | $10.2M | $20.2M | ||
| Q2 24 | $9.4M | $21.4M | ||
| Q1 24 | $8.4M | $19.3M |
| Q4 25 | $-8.7M | $-4.2M | ||
| Q3 25 | $-26.4M | $-8.2M | ||
| Q2 25 | $-21.6M | $-11.9M | ||
| Q1 25 | $-37.7M | $-14.2M | ||
| Q4 24 | $-36.3M | $-11.8M | ||
| Q3 24 | $-34.3M | $-11.1M | ||
| Q2 24 | $-25.3M | $-12.3M | ||
| Q1 24 | $-24.1M | $-16.3M |
| Q4 25 | 12.2% | 87.3% | ||
| Q3 25 | 11.5% | 86.4% | ||
| Q2 25 | 12.2% | 84.8% | ||
| Q1 25 | 12.6% | 86.2% | ||
| Q4 24 | 5.4% | 86.8% | ||
| Q3 24 | 13.8% | 83.9% | ||
| Q2 24 | 14.3% | 85.8% | ||
| Q1 24 | 9.4% | 85.5% |
| Q4 25 | -106.1% | -18.0% | ||
| Q3 25 | -149.4% | -39.7% | ||
| Q2 25 | -127.7% | -59.6% | ||
| Q1 25 | -135.6% | -79.2% | ||
| Q4 24 | -166.6% | -62.5% | ||
| Q3 24 | -176.0% | -55.7% | ||
| Q2 24 | -146.8% | -59.2% | ||
| Q1 24 | -122.9% | -76.4% |
| Q4 25 | -69.8% | -20.4% | ||
| Q3 25 | -216.6% | -41.0% | ||
| Q2 25 | -178.3% | -61.0% | ||
| Q1 25 | -324.6% | -80.8% | ||
| Q4 24 | -360.1% | -62.1% | ||
| Q3 24 | -335.2% | -54.9% | ||
| Q2 24 | -267.6% | -57.7% | ||
| Q1 24 | -286.9% | -84.4% |
| Q4 25 | $1.52 | $-0.07 | ||
| Q3 25 | $-1.18 | $-0.16 | ||
| Q2 25 | $-1.63 | $-0.23 | ||
| Q1 25 | $-4.32 | $-0.28 | ||
| Q4 24 | $-4.24 | $-0.23 | ||
| Q3 24 | $-4.01 | $-0.22 | ||
| Q2 24 | $-3.00 | $-0.25 | ||
| Q1 24 | $-2.89 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $92.0M |
| Total DebtLower is stronger | $483.1M | $42.4M |
| Stockholders' EquityBook value | $-166.2M | $63.9M |
| Total Assets | $410.5M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.2M | $92.0M | ||
| Q3 25 | $6.2M | $92.4M | ||
| Q2 25 | $5.3M | $101.5M | ||
| Q1 25 | $18.0M | $108.8M | ||
| Q4 24 | $937.0K | $120.4M | ||
| Q3 24 | $317.0K | $118.6M | ||
| Q2 24 | $9.7M | $118.2M | ||
| Q1 24 | $8.2M | $127.3M |
| Q4 25 | $483.1M | $42.4M | ||
| Q3 25 | $484.9M | $42.4M | ||
| Q2 25 | $478.3M | $42.4M | ||
| Q1 25 | $480.0M | $42.4M | ||
| Q4 24 | $436.8M | $40.0M | ||
| Q3 24 | $398.4M | $37.1M | ||
| Q2 24 | $374.0M | $35.0M | ||
| Q1 24 | $329.8M | $35.0M |
| Q4 25 | $-166.2M | $63.9M | ||
| Q3 25 | $-158.1M | $64.3M | ||
| Q2 25 | $-132.7M | $70.0M | ||
| Q1 25 | $-134.5M | $77.6M | ||
| Q4 24 | $-100.5M | $87.5M | ||
| Q3 24 | $-65.6M | $95.0M | ||
| Q2 24 | $-32.8M | $101.6M | ||
| Q1 24 | $-9.4M | $109.2M |
| Q4 25 | $410.5M | $115.3M | ||
| Q3 25 | $417.8M | $116.3M | ||
| Q2 25 | $426.8M | $122.0M | ||
| Q1 25 | $447.2M | $129.7M | ||
| Q4 24 | $428.0M | $142.8M | ||
| Q3 24 | $430.8M | $143.6M | ||
| Q2 24 | $438.1M | $149.7M | ||
| Q1 24 | $413.4M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.1M | $-1.8M |
| Free Cash FlowOCF − Capex | $-3.6M | $-2.0M |
| FCF MarginFCF / Revenue | -29.1% | -9.7% |
| Capex IntensityCapex / Revenue | 3.9% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-42.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.1M | $-1.8M | ||
| Q3 25 | $-8.9M | $-8.7M | ||
| Q2 25 | $-8.7M | $-7.5M | ||
| Q1 25 | $-9.6M | $-11.6M | ||
| Q4 24 | $1.2M | $-3.5M | ||
| Q3 24 | $-17.2M | $362.0K | ||
| Q2 24 | $-4.0M | $-9.5M | ||
| Q1 24 | $-7.1M | $-9.8M |
| Q4 25 | $-3.6M | $-2.0M | ||
| Q3 25 | $-10.1M | $-8.9M | ||
| Q2 25 | $-14.6M | $-7.8M | ||
| Q1 25 | $-14.5M | — | ||
| Q4 24 | $-8.6M | $-3.6M | ||
| Q3 24 | $-30.0M | $311.0K | ||
| Q2 24 | $-28.8M | $-9.5M | ||
| Q1 24 | $-42.1M | $-9.9M |
| Q4 25 | -29.1% | -9.7% | ||
| Q3 25 | -82.8% | -44.7% | ||
| Q2 25 | -121.0% | -39.6% | ||
| Q1 25 | -125.1% | — | ||
| Q4 24 | -85.3% | -18.9% | ||
| Q3 24 | -293.1% | 1.5% | ||
| Q2 24 | -305.4% | -44.7% | ||
| Q1 24 | -501.8% | -51.4% |
| Q4 25 | 3.9% | 0.8% | ||
| Q3 25 | 9.7% | 0.9% | ||
| Q2 25 | 48.9% | 1.1% | ||
| Q1 25 | 42.8% | 0.0% | ||
| Q4 24 | 97.6% | 0.7% | ||
| Q3 24 | 125.0% | 0.3% | ||
| Q2 24 | 263.0% | 0.4% | ||
| Q1 24 | 417.3% | 0.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LOCL
Segment breakdown not available.
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
